Health Care & Life Sciences » Pharmaceuticals | Zhejiang Jolly Pharmaceutical Co. Ltd.

Zhejiang Jolly Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
358
249
669
482
275
224
Total Accounts Receivable
115
214
229
309
325
390
Inventories
38
73
199
210
266
246
Other Current Assets
2
10
6
8
69
28
Total Current Assets
513
546
1,102
1,009
934
888
Net Property, Plant & Equipment
369
465
487
584
710
756
Total Investments and Advances
-
-
24
179
252
168
Intangible Assets
40
142
207
236
229
220
Other Assets
19
26
28
25
23
76
Total Assets
942
1,182
1,851
2,038
2,152
2,114
ST Debt & Current Portion LT Debt
100
112
186
277
303
Accounts Payable
20
52
52
71
133
Income Tax Payable
3
10
19
4
5
Other Current Liabilities
30
69
65
69
87
Total Current Liabilities
153
242
322
421
528
Long-Term Debt
-
42
68
121
110
Deferred Taxes
1
1
2
4
5
Total Liabilities
153
284
390
542
638
Common Equity (Total)
773
804
1,292
1,322
1,355
Total Shareholders' Equity
773
804
1,292
1,322
1,355
Total Equity
773
872
1,436
1,472
1,490
Liabilities & Shareholders' Equity
942
1,182
1,851
2,038
2,152
Accumulated Minority Interest
-
68
144
150
136
Non-Equity Reserves
16
26
25
24
24

About Zhejiang Jolly Pharmaceutical Co.

View Profile
Address
No. 388 Zhiyuan North Road
Huzhou Zhejiang 313200
China
Employees -
Website -
Updated 07/08/2019
Zhejiang Jolly Pharmaceutical Co., Ltd. engages in the research & development, production and distribution of pharmaceuticals as well as Chinese herbal medicines. Its products include wuling powder, wuling capsule, linglianhua particle, clindamycin phosphate injection, doxapram injection, pefloxacin mesylate injection, azithromycin injection and sodium nitroprusside injection. The company was founded on January 28, 2000 and is headquartered Huzhou, China.